Therapeutic Advances in Psychopharmacology

SAGE Publishing

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Psychopharmacology is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2045-1253 · 2045-1261
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,650 USD
Articles in DOAJ
343
Declared review time
10 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2019-07-04
Indexing
DOAJ
APC
2,650 USD
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

343

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

632

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

61

i10-index

317

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-04
Added to DOAJ
2019-07-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101555693
Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry

LCC codes

RM1-950RC435-571

Subject areas

  • Schizophrenia research and treatment
  • Schizophrenia research and treatment
  • Schizophrenia research and treatment
  • Treatment of Major Depression
  • Treatment of Major Depression
  • Treatment of Major Depression
  • Bipolar Disorder and Treatment
  • Bipolar Disorder and Treatment
Show all subjects (75)
  • Bipolar Disorder and Treatment
  • Tryptophan and brain disorders
  • Tryptophan and brain disorders
  • Electroconvulsive Therapy Studies
  • Psychiatric care and mental health services
  • Electroconvulsive Therapy Studies
  • Electroconvulsive Therapy Studies
  • Healthcare Decision-Making and Restraints
  • Healthcare Decision-Making and Restraints
  • Psychedelics and Drug Studies
  • Neurotransmitter Receptor Influence on Behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Psychedelics and Drug Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Psychedelics and Drug Studies
  • Mental Health Treatment and Access
  • Mental Health and Psychiatry
  • Medication Adherence and Compliance
  • Mental Health and Psychiatry
  • Pharmacogenetics and Drug Metabolism
  • Tryptophan and brain disorders
  • Mental Health and Psychiatry
  • Forensic Toxicology and Drug Analysis
  • Forensic Toxicology and Drug Analysis
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Pharmaceutical studies and practices
  • Historical Psychiatry and Medical Practices
  • Pharmaceutical Practices and Patient Outcomes
  • Obsessive-Compulsive Spectrum Disorders
  • Pharmaceutical Practices and Patient Outcomes
  • Attention Deficit Hyperactivity Disorder
  • Attention Deficit Hyperactivity Disorder
  • Mental Health Treatment and Access
  • Parkinson's Disease and Spinal Disorders
  • Mental Health Treatment and Access
  • Obsessive-Compulsive Spectrum Disorders
  • Parkinson's Disease and Spinal Disorders
  • Substance Abuse Treatment and Outcomes
  • Pain Management and Placebo Effect
  • Pharmacovigilance and Adverse Drug Reactions
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Pain Management and Placebo Effect
  • Family Caregiving in Mental Illness
  • Family Caregiving in Mental Illness
  • Sleep and related disorders
  • Epilepsy research and treatment
  • Pharmacovigilance and Adverse Drug Reactions
  • Epilepsy research and treatment
  • Pharmacology and Obesity Treatment
  • Parkinson's Disease Mechanisms and Treatments
  • Pharmacovigilance and Adverse Drug Reactions
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Posttraumatic Stress Disorder Research
  • Opioid Use Disorder Treatment
  • Dementia and Cognitive Impairment Research
  • Sleep and related disorders
  • Medication Adherence and Compliance
  • Forensic Toxicology and Drug Analysis
  • Psychotherapy Techniques and Applications
  • Medication Adherence and Compliance
  • Maternal Mental Health During Pregnancy and Postpartum
  • Stress Responses and Cortisol
  • Stress Responses and Cortisol
  • Maternal Mental Health During Pregnancy and Postpartum

Keywords (DOAJ)

  • psychopharmacology
  • mental health
  • psychiatry
  • mental disorders

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: